Bristol Myers Squibb Co. (BMY) Profile & Biotech Industry Trends Analysis 2011 (Related Reports)

Bristol Myers Squibb Co. (BMY) Profile & Biotech Industry Trends Analysis 2011


September 13, 2010
45 Pages - SKU: PLK2809015
License type:
Online Download      US $49.99
Global Site License      US $995.00
Ball Corp in Packaging (World)
3/26/2014 | published by: Euromonitor International
Ball Corp in Packaging (World) The leading metal packaging manufacturer, Ball, is working to address the challenges represented by maturity in key markets and the rise of rival packaging formats. This profile analyses Ball’s efforts to  |  read more...
$520.00
Personalized Medicine Partnering Terms and Agreements
4/1/2014 | published by: Current Partnering
Personalized Medicine Partnering Terms and Agreements Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The Personalized Medicine  |  read more...
$3,295.00
Biomarker Partnering Terms and Agreements
4/1/2014 | published by: Current Partnering
Biomarker Partnering Terms and Agreements The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.  |  read more...
$2,995.00
Alchemia Limited - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
Alchemia Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Alchemia Limited - Product Pipeline Review - 2014’, provides an overview of the Alchemia Limited’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
$1,500.00
Digna Biotech, S.L. - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
Digna Biotech, S.L. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Digna Biotech, S.L. - Product Pipeline Review - 2014’, provides an overview of the Digna Biotech, S.L.’s pharmaceutical research and development focus. This report provides  |  read more...
$1,500.00
PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding
3/12/2014 | published by: GlobalData
PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding Summary GlobalData’s PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding report provides in-depth analysis of  |  read more...
$2,995.00
Research and Development in Biotechnology Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 541711
3/11/2014 | published by: Plunkett Research, Ltd.
Research and Development in Biotechnology Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 541711 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours  |  read more...
$1,995.00
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
4/1/2014 | published by: Current Partnering
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter  |  read more...
$1,995.00
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics
4/1/2014 | published by: Current Partnering
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements  |  read more...
$2,995.00
Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
4/1/2014 | published by: Current Partnering
Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the  |  read more...
$2,995.00